GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » PB Ratio

Bristol-Myers Squibb Co (WBO:BMYS) PB Ratio : 7.30 (As of Dec. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-11), Bristol-Myers Squibb Co's share price is €55.57. Bristol-Myers Squibb Co's Book Value per Share for the quarter that ended in Sep. 2024 was €7.61. Hence, Bristol-Myers Squibb Co's PB Ratio of today is 7.30.

The historical rank and industry rank for Bristol-Myers Squibb Co's PB Ratio or its related term are showing as below:

WBO:BMYS' s PB Ratio Range Over the Past 10 Years
Min: 2.09   Med: 5.24   Max: 9.54
Current: 6.88

During the past 13 years, Bristol-Myers Squibb Co's highest PB Ratio was 9.54. The lowest was 2.09. And the median was 5.24.

WBO:BMYS's PB Ratio is ranked worse than
87.99% of 941 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs WBO:BMYS: 6.88

During the past 12 months, Bristol-Myers Squibb Co's average Book Value Per Share Growth Rate was -40.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -5.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 3.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bristol-Myers Squibb Co was 33.60% per year. The lowest was -13.50% per year. And the median was 3.90% per year.

Back to Basics: PB Ratio


Bristol-Myers Squibb Co PB Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co PB Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.75 3.59 3.73 4.77 3.47

Bristol-Myers Squibb Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.13 3.47 6.71 5.04 6.03

Competitive Comparison of Bristol-Myers Squibb Co's PB Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's PB Ratio falls into.



Bristol-Myers Squibb Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Bristol-Myers Squibb Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=55.57/7.614
=7.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Bristol-Myers Squibb Co  (WBO:BMYS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Bristol-Myers Squibb Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines